本文選題：子宮內(nèi)膜異位癥 + 復(fù)發(fā)�。� 參考：《現(xiàn)代婦產(chǎn)科進(jìn)展》2017年02期

【摘要】：目的:探討子宮內(nèi)膜異位癥(EMs)非根治術(shù)后復(fù)發(fā)并行二次手術(shù)患者的臨床特點(diǎn)。方法:回顧分析2010年1月至2015年8月于浙江大學(xué)醫(yī)學(xué)院附屬婦產(chǎn)科醫(yī)院行二次手術(shù)治療的290例EMs復(fù)發(fā)患者的臨床資料。結(jié)果:290例患者二次手術(shù)平均間隔為(5.96±3.38)年,初次手術(shù)年齡大、初次手術(shù)r-AFS分期越高的患者的兩次手術(shù)間隔時(shí)間短(P0.05),初次手術(shù)為半根治手術(shù)或單側(cè)卵巢切除、術(shù)后有生育史的患者的兩次手術(shù)間隔時(shí)間長(zhǎng)(P0.05)。有腺肌病史、初次手術(shù)r-AFS分期高的患者的復(fù)發(fā)分期明顯高于無(wú)腺肌病史、初次手術(shù)r-AFS分期低者(P0.05)。4.0%接受術(shù)后短期輔助藥物治療(≤6月)的患者1年內(nèi)接受二次手術(shù),12.2%未接受藥物治療的患者在1年內(nèi)接受二次手術(shù)。結(jié)論:EMs初次手術(shù)分期高、有腺肌病史是復(fù)發(fā)的危險(xiǎn)因素,初次保守手術(shù)單側(cè)卵巢切除或者子宮切除及術(shù)后生育是延長(zhǎng)二次手術(shù)間隔的保護(hù)因素。術(shù)后短期輔助藥物治療(≤6月)對(duì)降低術(shù)后1年內(nèi)二次手術(shù)率有意義,但對(duì)延長(zhǎng)遠(yuǎn)期二次手術(shù)間隔無(wú)明顯意義。
[Abstract]:Objective: to investigate the clinical features of patients with recurrent and secondary operations after non-radical resection of endometriosis. Methods: the clinical data of 290 patients with recurrent EMs were retrospectively analyzed from January 2010 to August 2015 in the Department of Obstetrics and Gynecology affiliated to Zhejiang University School of Gynaecology and Obstetrics. Results the average interval of second operation in 290 patients was 5.96 鹵3.38 years. The patients with older age and higher r-AFS stage had shorter interval (P 0.05) and half radical operation or unilateral ovariectomy. There was a long interval between two operations in patients with a history of childbirth after surgery (P 0.05). The recurrent stage of adenomyosis in patients with high r-AFS stage in the first operation was significantly higher than that in the patients without adenomyosis. Among the patients with low r-AFS staging, 4.0% received postoperative short-term adjuvant drug therapy (鈮，

本文編號(hào)：2007756